The March of Transcatheter Aortic Valve Replacement Therapy-US Food and Drug Administration Perspectives on Device Approval for Patients at Low Surgical Risk.

Subjects

Subjects :

Age Factors
Aortic Valve surgery
Decision Making, Shared
Heart Valve Prosthesis Implantation
Humans
Patient Selection
Product Labeling
Prosthesis Failure
Risk
Severity of Illness Index
United States
United States Food and Drug Administration
Aortic Valve pathology
Aortic Valve Stenosis surgery
Calcinosis surgery
Device Approval
Heart Valve Prosthesis
Transcatheter Aortic Valve Replacement methods

Details

Language :

English

ISSN :

2380-6591

Volume :

5

Issue :

1

Database :

MEDLINE

Journal :

JAMA cardiology

Publication Type :

Academic Journal

Accession number :

31721988

Full Text :

https://doi.org/10.1001/jamacardio.2019.4383